World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon
BioNTech at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
BioNTech takes part in 3 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions span cancer and infectious disease, from regulatory hurdles for multi-modality cancer immunotherapy to balancing speed and safety in global vaccine access. The most concrete covers the design and development of mRNA-encoded tuberculosis vaccines.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
BioNTech Mainz, Germany | |
Develops mRNA vaccines and immunotherapies for infectious diseases and cancer, including the marketed COVID-19 vaccine Comirnaty. | Talk Mon Oct 19 10:15 Talk Mon Oct 19 15:00 Panel: Global Vaccine Access: Balancing Speed and Safety How regulators worldwide can speed vaccine approval, for example by relying on other agencies' reviews, without weakening safety checks. Talk Wed Oct 21 12:30 |
Find decision makers at BioNTech
Tell us what you sell and we’ll find the people at BioNTech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction